Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe’s largest vertically integrated cannabis company, is pleased to announce it has successfully exported over one metric ton of medical cannabis to BOL Pharma in Israel. Curaleaf International is one of the first companies to export medical cannabis to Israel under the country’s new regulatory regime. The initial shipment, comprising two strains of dried flower, was shipped from Curaleaf International’s primary cultivation facility, Terra Verde in Portugal, and is part of a larger supply agreement with BOL Pharma. Kfir Avraham, CEO of BOL Pharma, added: “We are pleased to be working with Curaleaf International to bring new medical cannabis products to market. We are witnessing a significant rise in patient demand for high-quality medical cannabis products in Israel and Curaleaf International is a trusted partner to deliver consistent and reliable products to meet our market requirements.
Mmp News Author, Medical Marijuana Program Connection, 07/08/2021 02:48:00